Podcast: Challenges in the Development and Manufacturing of ADCs

Sep 24 2024

• By Scrip Team

Sponsored by

Explore smart strategies for overcoming ADC development and manufacturing challenges. Find your way forward in this exciting, evolving area. Listen now as experts from Olon Group share their insights with Citeline. Listen now, and explore topics including:

• How ADCs are transforming the pharma industry

• Overcoming critical technical challenges in ADC manufacturing and ADC purification across the value chain

• Leveraging Design of Experiments (DoE) advantages in the chemical development of ADCs

• Outsourcing all parts of ADC manufacturing to a single CDMO: pros and cons

• New and unique ADC capabilities at Olon

• Emerging and future challenges for ADCs

Enjoyed this podcast? find part two here.

Executives On The Move: Three New CEOs And Five New CMOs Among This Week’s Changes

Sep 18 2025

Recent moves in the industry include changes at the top at Vyome Holdings, CoRegen and Resolution Therapeutics, plus Takeda hires Rhonda Pacheco from Eli Lilly as the President of its US unit.

Takeda APAC Head On ‘Conscious’ Pricing, Qdenga And Reverse Digital Mentoring

Sep 17 2025

• By Anju Ghangurde

Takeda's APAC chief talks about driving affordability and access for products like Adcetris and Qdenga, focusing on the region's diverse needs. “Watch this space” he said on the Japanese group’s Innovation Capability Centers, as they shape digital solutions to transform operations.

Novartis Sticks With Monte Rosa In Search For New Molecular Glue Degraders

Sep 16 2025

• By Manas Mishra

The collaboration continues a hot streak for deals in the molecular glue degrader space and adds to Novartis’s recent string of acquisitions and licensing deals.